We are live on ! Find out more
BCDAW

BioCardia, Inc. Warrant

Delisted

BCDAW was delisted on the 2nd of August, 2024.

7 hedge funds and large institutions have $1.58K invested in BioCardia, Inc. Warrant in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more funds holding

Funds holding: 47 (+3)

9% more capital invested

Capital invested by funds: $1.45K → $1.58K (+$127)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
7
Holders Change
+3
Holders Change %
+75%
% of All Funds
0.1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$745 +$294 +14,771 +34%
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$341 +$534 +26,827 New
G
3
GenTrust
Florida
$196
UBS Group
4
UBS Group
Switzerland
$130 +$200 +10,030 New
Osaic Holdings
5
Osaic Holdings
Arizona
$95 -$418 -21,030 -69%
Bank of America
6
Bank of America
North Carolina
$69
CS
7
Clear Street
New York
$1 +$2 +100 New

BCDAW Hedge Fund Activity: Q2 2024 in Review

7 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in BioCardia, Inc. Warrant (BCDAW) for Q2 2024, worth a combined $1.58K — up 8.8% from $1.45K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new BCDAW positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $534. The largest seller was Osaic Holdings, cutting an estimated $418.

  • 7 institutional investors held BioCardia, Inc. Warrant (BCDAW) as of Q2 2024, up from 4 in Q1 2024.
  • Funds reported $1.58K of BioCardia, Inc. Warrant stock for Q2 2024, up 8.8% quarter-over-quarter.
  • 3 funds opened new BioCardia, Inc. Warrant positions in Q2 2024 and 0 closed out, a net change of +3 holders.
  • The largest BioCardia, Inc. Warrant buyer in Q2 2024 was Susquehanna International Group, an estimated $534 added.
  • The largest BioCardia, Inc. Warrant seller in Q2 2024 was Osaic Holdings, an estimated $418 sold.

Based on aggregated 13F filings for Q2 2024.